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Introduction: The Gut-Brain Axis
in Parkinson’s Disease
Teus van Laar
Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands
This special edition on the gut-brain axis in Parkin-
son’s disease is one in a very long list of publications
on this theme during recent years. If one searches in
PubMed on ‘Parkinson and Gut’, the data show that
especially the last 3 years the interest in this topic has
grown tremendously. From 1969, showing the first
2 references on this topic, up to 2008, the number
of publications stayed below 10 per year. However,
since 2008 the number of publications has increased
to over 110 in 2019.
This interest fits in the overall increased attention
of researchers and the public on the role of food and
other environmental factors on health. The gut-brain
axis discussion therefore is not restricted to PD, but
also includes other neurodegenerative- and brain dis-
eases like autism, depression, multiple sclerosis and
Alzheimer disease, which directly gives rise to ques-
tions about causal relationships. Are we looking at
epiphenomena in different diseases, or could it be
that specific changes in the gut are the pivotal factor
in the pathogenesis of multiple brain disorders, and
if so, how?
The current edition of JPD has become a compre-
hensive and up to date summary of the most important
PD-related discussions at this moment, revealing the
enormous complexity of the topic, which unfortu-
nately leaves several questions open. Does PD start
in all patients in the gut, or is this route related to a
small subgroup of patients? Is there a peripheral and a
central route of getting PD? What is the role of consti-
pation, and what does it mean if patients do not have
constipation? What is the effect of constipation on the
microbiome and what other factors might be related
to constipation.? Does the presence of constipation
lead to a different subtype of PD?
Changes in microbiome composition between PD
and healthy controls (HC) are extensively discussed.
It is clear that, despite all the methodological issues,
the microbiome in PD is really different from HC.
This is supported by data showing that these dif-
ferences become more significant over time. This
suggests that microbiome changes are not only a start-
ing point of PD, but part of the disease progression.
However, the inhomogeneity in study design, sam-
pling, lab processes, sequencing methods and the
variety in confounders really impair the final con-
clusions.
The most complex part of this special edition is
about the interplay between microbiome changes,
metabolomics, local-, systemic- and brain inflam-
mation, gut wall permeability, aSyn production,
-accumulation and -transport, and the risk on PD or
PD progression.
The problem here is how to establish causality.
What is first, and do the causal events vary between
the different subtypes of PD? The complexity is par-
tially caused by the fact that multiple systems take
part in the communication between gut and brain,
existing of neuronal pathways, besides endocrine-
and immunological connections.
Finally the role of aSyn is discussed extensively.
On one hand aSyn is discussed as a toxic agent if
aggregates are being formed, but on the other hand
intrigueing data are presented on aSyn as a media-
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tor of immunological responses, preventing and/or
reducing inflammation.
The ultimate question is if this bunch of data will
lead to new therapeutic options. Several trials are
running at this moment, but so far no definite new
treatments have become available.
Hopefully, this special issue will contribute to new
insights and new trials, finally leading to a better life
for patients with PD.
Groningen, September 2019
